Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Peter Clark, MA, MD, FRCP: A Payer Perspective

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Advertisement

Advertisement




Dec
05
Today In Oncology
ASCO Statement on Departure of Richard Pazdur From FDA
Mammography-Based Outreach Increases Lung Cancer Screening Enrollment in Eligible Women
Pancreatic Cancer Detection AI vs Radiologists
Are Glycemic Index and Load Associated With Lung Cancer Risk
Upfront Reduced-Dose Enfortumab Vedotin With Pembrolizumab in First-Line Treatment of Advanced Urothelial Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo